Plasma homocysteine and methionine concentrations in children with neural tube defects

European Journal of Pediatric Surgery, Supplement

Volumn 6, Issue 1, 1996, Pages 7-9

  Graf, W D ^a   Oleinik, O E ^a   Jack, Rhona M ^a   Eder, D N ^a   Shurtleff, D B ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

children; neural tube defects; plasma homocysteine and methionine

Indexed keywords

HOMOCYSTEINE; METHIONINE;

BLOOD LEVEL; CHILD; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; HUMAN; HYPERHOMOCYSTEINEMIA; MALE; NEURAL TUBE DEFECT;

EID: 0030473511     PISSN: 09396764     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1071028     Document Type: Article

References (18)

1. Adams JM Jr, Khoury MJ, Scanlon KS, Stevenson RE, Knight GJ, Haddow JE, Sylvester GC, Cheek JE, Henry JP, Stabler SP, Allen RH: Elevated midtrimester serum methylmalonic acid levels as a risk factor for neural tube defects. Teratology 51 (1995) 311-317
2. Armstrong MD, Stave U: A study of plasma free amino acid levels. II. Normal values for children and adults. Metabolism 22 (1973) 561-569
3. Armstrong MD, Stave U: A study of plasma free amino acid levels III. Variations during growth and aging. Metabolism 22 (1973) 571-578
4. Brattström I., Israelsson B, Norrving B, Bergqvist D, Thörne J, Hultberg B, Hamfelt A: Impaired homocysteine metabolism in early onset cerebral and peripheral occlusive disease - effects of pyndoxine and folic acid treatment Atherosclerosis 81 (1990) 2004-2006
5. Castagna A, Le Grazie C, Accordini A, Giulidori P, Cavalli G, Bottiglier T, Lazzarin A: Cerebrospinal fluid S-adenosylmethionme (SAMe) and glutathione concentrations in HIV infection: Effect of parenteral treatment with SAMe. Neurology 45 (1995) 1678-1683
6. Franken DG, Boers GH, Blom HJ, Trijbels JM: Effect of various regimens of Vilamin B 6 and folic acid on mild hyperhomocysteinemia in vascular patients J Inherit Metab Dis 17 (1994) 159-162
7. Holmgren G: Effect of low, normal and high dietary protein intake on urinary ammo acid excretion and plasma aminogram in children. Nutr Metabolism 16 (1974) 223-237
8. Kang SS, Wong P, Susmano A, Sora J, Norusis M, Ruggie N: Thermolabile methylene-tetrahydrofolate reductase. an inherited risk factor for coronary artery disease. Am J Hum Genet 48 (1991) 536-545
9. Miller JW, Nadeau MR, Smith J, Smith D, Selhub J: Folate-deficiency-induced homocysteinemia in rats: disruption of S-adenosytmethionine's co-ordinate regulation of homocysteine metabolism Biochem J 298 (1994) 415-419
10. Mills JL, McPartlin JM, Peadar JK, Young JL, Conley MR, Wier DG, Scott JM: Homocysteine metabolism in pregnancies complicated by neural tube defects Lancet 345 (1995) 149-151
11. Rasmussen K, Møller J, Lyngbak M, Pedersen A-MH, Dybkjaer L: Ageand gender-specific reference intervals for total homocysteine and methylmalonic acid in plasma before and after vitamin supplementation. Clin Chem 42 (1996) 630-636
12. Refsum H, Wesenberg F, Ueland PM: Plasma homocysteine in children with acute lymphoblastic leukemia, changes during a chemotherapeutic regimen including methotrexate Cancer Res 51 (1991) 828-835
13. Selhub J, Jacques PF, Wilson PWF, Rush D, Rosenberg IH: Vitamin status and intake as primary determinants of homocysteinemia in an elderly population JAMA 270 (1993) 2693-2698
14. Shurtleff DB: Computer data bases for pediatric disability: clinical and research applications. Physical Medicine and Rehabilitation Clinics of North America 2 (1991) 665-687
15. SPSS for Windows: Version 6.0 Chicago: SPSS, 1993
16. Steegers-Theunissen RPM, Boers GHJ, Trijbels FJM, Finkelstein JD, Blom HJ, Thomas CMC, Borm GF, Wouters MGAJ, Eskes TKAB: Maternal hyperhomocysteinemia A risk factor for neural tube defects? Metabolism 43 (1994) 1475-1480
17. Ubbink JB, Vermark WJH, Bissbort S: Rapid HPLC assay for total homocysteine levels in human serum. J Chromatogr 565 (1991) 441-146
18. van der Put NMJ, Steegers-Theunissen RPM, Frosst P, Trijbels FJM, Eskes TKAB, van den Heuvel LP, Mariman ECM, den Heyer M, Rosen R, Blom HJ: Mutated methylene-tetrahydrofolate reductase as a risk factor for spina bifida. The Lancet 346 (1995) 1070-1071